In Vitro Analysis of Cytotoxic Activities of Monotheca buxifolia Targeting WNT / β-Catenin Genes in Breast Cancer Cells.
Ambreen SherSobia TabassumHeather Mann WallaceAsifullah KhanAsad-Mustafa KarimSarah GulSe-Chan KangPublished in: Plants (Basel, Switzerland) (2023)
Breast cancer (BC) is known to be the most common malignancy among women throughout the world. Plant-derived natural products have been recognized as a great source of anticancer drugs. In this study, the efficacy and anticancer potential of the methanolic extract of Monotheca buxifolia leaves using human breast cancer cells targeting WNT / β-catenin signaling was evaluated. We used methanolic and other (chloroform, ethyl acetate, butanol, and aqueous) extracts to discover their potential cytotoxicity on breast cancer cells (MCF-7). Among these, the methanol showed significant activity in the inhibition of the proliferation of cancer cells because of the presence of bioactive compounds, including phenols and flavonoids, detected by a Fourier transform infrared spectrophotometer and by gas chromatography mass spectrometry. The cytotoxic effect of the plant extract on the MCF-7 cells was examined by MTT and acid phosphatase assays. Real-time PCR analysis was performed to measure the mRNA expression of WNT-3a and β-catenin , along with Caspase-1,-3,-7, and -9 in MCF-7 cells. The IC50 value of the extract was found to be 232 μg/mL and 173 μg/mL in the MTT and acid phosphatase assays, respectively. Dose selection (100 and 300 μg/mL) was performed for real-time PCR, Annexin V/PI analysis, and Western blotting using Doxorubicin as a positive control. The extract at 100 μg/mL significantly upregulated caspases and downregulated the WNT-3a and β-catenin gene in MCF-7 cells. Western blot analysis further confirmed the dysregulations of the WNT signaling component (*** p< 0.0001). The results showed an increase in the number of dead cells in methanolic extract-treated cells in the Annexin V/PI analysis. Our study concludes that M. buxifolia may serve as an effective anticancer mediator through gene modulation that targets WNT / β-catenin signaling, and it can be further characterized using more powerful experimental and computational tools.
Keyphrases
- breast cancer cells
- induced apoptosis
- cell proliferation
- cell cycle arrest
- oxidative stress
- stem cells
- endoplasmic reticulum stress
- signaling pathway
- gas chromatography mass spectrometry
- epithelial mesenchymal transition
- cancer therapy
- genome wide
- drug delivery
- risk assessment
- type diabetes
- south africa
- endothelial cells
- pregnant women
- genome wide identification
- metabolic syndrome
- high resolution
- human health
- liquid chromatography
- protein kinase
- solid phase extraction
- insulin resistance